Toshiba (TYO:6502) said today it completed its acquisition of medical imaging application developer Olea Medical following approval from the French Ministry of Economy.

Toshiba said it will use the acquisition to grow its MRI business by offering Olea’s software for advanced post-processing and image analysis as well as its relationships and agreements with research institutions and customers.

“This partnership means we will benefit from both Toshiba and Olea’s strengths to accelerate innovation and enhance our global presence. Through the integration of both R&D teams we believe we could bring the innovative solutions and products to play an important role in the development of MRI systems,” Toshiba medical systems CEO Toshio Takiguchi said in a press release.

The acquisition will allow Toshiba to provide multi-modality solutions by integrating Olea’s post-processing software with Toshiba subsidiary Vital Image’s Vitrea software to allow collaboration and consolidation of workflows, the company said.

“This is great news for Olea’s customers and our fabulous team, and we are happy and proud to join the Toshiba family. We are convinced this is the right strategy to pursue our commitment to provide a widely accessible, complete package of simple, safe, fast, and accurate tools for full-body image post processing, in order to help doctors improve the diagnosis and follow-up process for patients’ benefit worldwide,” Olea Medical CEO Fayçal Djeridane said in prepared remarks.

Toshiba’s Vital Image signed a partnership with Olea back in 2012 to provide integrated thin-client advanced neurological MR solutions using Vital’s Vitrea Advanced software.